These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2639975)

  • 41. [Palpitin--an anti-arrhythmic drug in ischemic heart disease].
    Kuch J; Mamcarz A; Król J; Sawicki J; Braksator W
    Wiad Lek; 1990 Jan 1-15; 43(1-2):23-7. PubMed ID: 2114703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of intravenous mexiletine and lidocaine for the treatment of ventricular arrhythmias.
    Lui HK; Harris FJ; Chan MC; Lee G; Mason DT
    Am Heart J; 1986 Dec; 112(6):1153-8. PubMed ID: 3788761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of practolol on the dysrhythmias complicating acute ischemic heart disease.
    Allen JD; Pantridge JF; Shanks RG
    Am J Med; 1975 Feb; 58(2):199-208. PubMed ID: 1115067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous lorcainide for symptomatic ventricular tachyarrhythmias: comparison with lidocaine and oral lorcainide.
    Hohnloser SH; Podrid PJ; Lown B
    Am Heart J; 1988 Apr; 115(4):824-30. PubMed ID: 3354411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of lidocaine in ventricular arrhythmias.
    Anderson GA
    Am Fam Physician; 1976 Jun; 13(6):118-9. PubMed ID: 1274814
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular arrhythmias.
    Hilleman DE; Mohiuddin SM; Mooss AN; Hunter CB; Destache CJ; Sketch MH
    Ann Pharmacother; 1992 Jun; 26(6):763-7. PubMed ID: 1611156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventional treatment for ventricular arrhythmias: the initial South Carolina case.
    Stewart D; Finch N; Kratz J; Leman RB
    J S C Med Assoc; 1990 Jun; 86(6):341-5. PubMed ID: 2398732
    [No Abstract]   [Full Text] [Related]  

  • 50. Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance.
    Vozeh S; Uematsu T; Ritz R; Schmidlin O; Kaufman G; Scholer A; Follath F
    Am Heart J; 1987 Apr; 113(4):928-33. PubMed ID: 3565242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.
    Alderman EL; Kerber RE; Harrison DC
    Am J Cardiol; 1974 Sep; 34(3):342-9. PubMed ID: 4851926
    [No Abstract]   [Full Text] [Related]  

  • 52. Intravenous lorcainide versus lidocaine in the treatment of frequent and complex ventricular arrhythmias.
    Blevins RD; Kerin NZ; Mathias P; Pesola D; Faitel K; Jarandilla R; Garfinkel C; Rubenfire M
    Am Heart J; 1986 Mar; 111(3):447-51. PubMed ID: 3953351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion.
    Estes NA; Manolis AS; Greenblatt DJ; Garan H; Ruskin JN
    Am Heart J; 1989 May; 117(5):1060-4. PubMed ID: 2711965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [2% Xylocaine in the treatment of heart arrhythmias of the ventricular type].
    Kalauzi J
    Med Arh; 1975; 29(6):635-40. PubMed ID: 1214535
    [No Abstract]   [Full Text] [Related]  

  • 56. Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure.
    Wyman MG; Slaughter RL; Farolino DA; Gore S; Cannom DS; Goldreyer BN; Lalka D
    J Am Coll Cardiol; 1983 Oct; 2(4):764-9. PubMed ID: 6886235
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results obtained in controlling arrhythmias of different types with oral and parenteral lidocaine doses.
    Böszörményi E; Morvai V; Farsang C
    Ther Hung; 1978; 26(3):111-8. PubMed ID: 725814
    [No Abstract]   [Full Text] [Related]  

  • 60. Prophylactic lidocaine in suspected acute myocardial infarction.
    Dunn HM; Kinney CD; Campbell NP; Shanks RG; Adgey AA
    Int J Cardiol; 1984 Jan; 5(1):96-8. PubMed ID: 6693216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.